JP2010532745A - 疼痛の処置のためのスフェンタニル含有小容量経口腔粘膜用剤形 - Google Patents
疼痛の処置のためのスフェンタニル含有小容量経口腔粘膜用剤形 Download PDFInfo
- Publication number
- JP2010532745A JP2010532745A JP2009544900A JP2009544900A JP2010532745A JP 2010532745 A JP2010532745 A JP 2010532745A JP 2009544900 A JP2009544900 A JP 2009544900A JP 2009544900 A JP2009544900 A JP 2009544900A JP 2010532745 A JP2010532745 A JP 2010532745A
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- sufentanil
- drug
- administration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002552 dosage form Substances 0.000 title claims abstract description 497
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 title claims abstract description 259
- 229960004739 sufentanil Drugs 0.000 title claims abstract description 252
- 208000002193 Pain Diseases 0.000 title claims abstract description 89
- 230000036407 pain Effects 0.000 title claims abstract description 68
- 238000011282 treatment Methods 0.000 title description 36
- 210000000214 mouth Anatomy 0.000 title description 23
- 210000004877 mucosa Anatomy 0.000 title description 9
- 239000003814 drug Substances 0.000 claims abstract description 285
- 229940079593 drug Drugs 0.000 claims abstract description 276
- 238000000034 method Methods 0.000 claims abstract description 77
- 239000000203 mixture Substances 0.000 claims abstract description 65
- 210000002200 mouth mucosa Anatomy 0.000 claims abstract description 60
- 239000003826 tablet Substances 0.000 claims description 60
- 230000003628 erosive effect Effects 0.000 claims description 55
- 210000003296 saliva Anatomy 0.000 claims description 52
- 238000009472 formulation Methods 0.000 claims description 51
- 208000005298 acute pain Diseases 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000227 bioadhesive Substances 0.000 claims description 17
- 239000007787 solid Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 15
- 239000007937 lozenge Substances 0.000 claims description 13
- 210000004379 membrane Anatomy 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- 208000000003 Breakthrough pain Diseases 0.000 claims description 7
- 208000004550 Postoperative Pain Diseases 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 210000005178 buccal mucosa Anatomy 0.000 claims 1
- 238000012384 transportation and delivery Methods 0.000 description 89
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 70
- 230000006870 function Effects 0.000 description 34
- 238000010586 diagram Methods 0.000 description 32
- 229960002428 fentanyl Drugs 0.000 description 28
- 239000013543 active substance Substances 0.000 description 25
- 241000282414 Homo sapiens Species 0.000 description 24
- 239000002274 desiccant Substances 0.000 description 22
- 230000036470 plasma concentration Effects 0.000 description 22
- 238000012377 drug delivery Methods 0.000 description 21
- 229940060201 actiq Drugs 0.000 description 17
- 229940021271 fentora Drugs 0.000 description 17
- 238000003032 molecular docking Methods 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 15
- 210000003128 head Anatomy 0.000 description 15
- 230000002496 gastric effect Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 238000004891 communication Methods 0.000 description 12
- 239000010408 film Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 238000001802 infusion Methods 0.000 description 11
- -1 troches Substances 0.000 description 11
- 230000000202 analgesic effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000011888 foil Substances 0.000 description 10
- 238000007726 management method Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 238000004088 simulation Methods 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 210000004400 mucous membrane Anatomy 0.000 description 8
- 229940005483 opioid analgesics Drugs 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000000017 hydrogel Substances 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 6
- 230000002745 absorbent Effects 0.000 description 6
- 239000002250 absorbent Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
- 239000006186 oral dosage form Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 239000007909 solid dosage form Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000009747 swallowing Effects 0.000 description 6
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 5
- 229960001391 alfentanil Drugs 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 230000035587 bioadhesion Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- ZTVQQQVZCWLTDF-UHFFFAOYSA-N Remifentanil Chemical compound C1CN(CCC(=O)OC)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 ZTVQQQVZCWLTDF-UHFFFAOYSA-N 0.000 description 4
- OJCZPLDERGDQRJ-UHFFFAOYSA-N Sufentanil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 OJCZPLDERGDQRJ-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- YDSDEBIZUNNPOB-UHFFFAOYSA-N carfentanil Chemical compound C1CN(CCC=2C=CC=CC=2)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 YDSDEBIZUNNPOB-UHFFFAOYSA-N 0.000 description 4
- 229950004689 carfentanil Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000006196 drop Substances 0.000 description 4
- 229950010274 lofentanil Drugs 0.000 description 4
- IMYHGORQCPYVBZ-NLFFAJNJSA-N lofentanil Chemical compound CCC(=O)N([C@@]1([C@@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 IMYHGORQCPYVBZ-NLFFAJNJSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 229960003394 remifentanil Drugs 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229960001204 sufentanil citrate Drugs 0.000 description 4
- RJSCINHYBGMIFT-UHFFFAOYSA-N trefentanil Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(C=1C=CC=CC=1)N(C(=O)CC)C1=CC=CC=C1F RJSCINHYBGMIFT-UHFFFAOYSA-N 0.000 description 4
- 229950003235 trefentanil Drugs 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 3
- 206010038678 Respiratory depression Diseases 0.000 description 3
- 206010051259 Therapy naive Diseases 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000013583 drug formulation Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229960005181 morphine Drugs 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000004894 snout Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000000094 Chronic Pain Diseases 0.000 description 2
- 206010069803 Injury associated with device Diseases 0.000 description 2
- 241000931888 Pyxis Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000000599 controlled substance Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000007580 dry-mixing Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000002650 laminated plastic Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 239000002991 molded plastic Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229940051877 other opioids in atc Drugs 0.000 description 2
- 210000003254 palate Anatomy 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000006190 sub-lingual tablet Substances 0.000 description 2
- 229940028426 sufenta Drugs 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- 241001535291 Analges Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 208000012488 Opiate Overdose Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000009246 art therapy Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000029771 childhood onset asthma Diseases 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000008406 drug-drug interaction Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 210000002643 mouth floor Anatomy 0.000 description 1
- 102000051367 mu Opioid Receptors Human genes 0.000 description 1
- 239000002623 mu opiate receptor antagonist Substances 0.000 description 1
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 description 1
- 229960003086 naltrexone Drugs 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 description 1
- 239000003402 opiate agonist Substances 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000033300 receptor internalization Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 108020001612 μ-opioid receptors Proteins 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Primary Health Care (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/650,174 US8202535B2 (en) | 2006-01-06 | 2007-01-05 | Small-volume oral transmucosal dosage forms |
| US11/985,162 US8865743B2 (en) | 2006-01-06 | 2007-11-14 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| PCT/US2007/089018 WO2008085765A2 (en) | 2007-01-05 | 2007-12-28 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010532745A true JP2010532745A (ja) | 2010-10-14 |
| JP2010532745A5 JP2010532745A5 (enExample) | 2011-02-24 |
Family
ID=39609243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009544900A Pending JP2010532745A (ja) | 2007-01-05 | 2007-12-28 | 疼痛の処置のためのスフェンタニル含有小容量経口腔粘膜用剤形 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US8865743B2 (enExample) |
| EP (1) | EP2114383B1 (enExample) |
| JP (1) | JP2010532745A (enExample) |
| KR (1) | KR101545754B1 (enExample) |
| AT (1) | ATE474564T1 (enExample) |
| CA (1) | CA2673856C (enExample) |
| DE (1) | DE602007007991D1 (enExample) |
| DK (1) | DK2114383T3 (enExample) |
| PT (1) | PT2114383E (enExample) |
| WO (1) | WO2008085765A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016510345A (ja) * | 2014-02-07 | 2016-04-07 | サイラブス, ファーマシューティカルズ | 全自然非毒性舌下薬剤の送達システム |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
| US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
| US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| JP2010518086A (ja) | 2007-02-09 | 2010-05-27 | デュレクト コーポレーション | スフェンタニルおよびナロキソンを含む経口腔投与製剤 |
| JP5632284B2 (ja) * | 2007-08-07 | 2014-11-26 | エーセルアールエックス ファーマシューティカルズ, インコーポレイテッド | 経口経粘膜剤形を使用する処置時の鎮静および無痛のための組成物および方法 |
| US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| US8548623B2 (en) | 2009-03-18 | 2013-10-01 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| US20110050412A1 (en) * | 2009-08-18 | 2011-03-03 | Cynthia Wittman | Voice activated finding device |
| US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| US20110218595A1 (en) * | 2010-03-04 | 2011-09-08 | Mcmillan William C | Prescription device controller |
| US20110288128A1 (en) | 2010-05-21 | 2011-11-24 | Acelrx Pharmaceuticals, Inc. | Oral Transmucosal Administration of Sufentanil |
| GB201014783D0 (en) * | 2010-09-06 | 2010-10-20 | St George S Hospital Medical School | Apparatus and method for positioning a probe for observing microcirculation vessels |
| US20130020351A1 (en) * | 2011-07-21 | 2013-01-24 | Gojo Industries, Inc. | Dispenser with optical keying system |
| PE20142444A1 (es) | 2012-05-02 | 2015-01-09 | Orexo Ab | Nueva composicion de alfentanilo para el tratamiento del dolor agudo |
| TWI689326B (zh) * | 2014-08-06 | 2020-04-01 | 加拿大商複製細胞生命科學公司 | 注射裝置 |
| NZ732808A (en) | 2014-12-23 | 2021-12-24 | Acelrx Pharmaceuticals Inc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
| FR3032353B1 (fr) | 2015-02-06 | 2017-03-10 | Jacques Seguin | Composition pharmaceutique et dispositif pour le traitement de la douleur |
| SE539111C2 (en) * | 2015-06-03 | 2017-04-11 | Iconovo Ab | Single dose dry powder inhaler |
| DK3682915T3 (da) | 2015-10-30 | 2023-06-19 | Acelrx Pharmaceuticals Inc | Anordning og fremgangsmåder til afgivelse af orale transmucosale doseringsformer |
| JP2017112241A (ja) * | 2015-12-17 | 2017-06-22 | ルネサスエレクトロニクス株式会社 | 半導体装置 |
| US9731103B1 (en) | 2017-01-13 | 2017-08-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration devices and associated systems and methods |
| US10792226B2 (en) | 2017-06-07 | 2020-10-06 | Berkshire Biomedical, LLC | Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices |
| US10441509B2 (en) | 2018-03-16 | 2019-10-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods |
| US10597206B2 (en) | 2018-06-15 | 2020-03-24 | Kenneth Corey | Medicine container cover |
| US10729860B1 (en) | 2019-05-22 | 2020-08-04 | Berkshire Biomedical, LLC | Computerized oral prescription administration for securely dispensing a medication and associated systems and methods |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002526440A (ja) * | 1998-09-24 | 2002-08-20 | ダイアバクト・エイ・ビー | 急性疼痛の処置のためのフェンタニル組成物 |
| JP2003512402A (ja) * | 1999-10-27 | 2003-04-02 | アネスタ・コーポレーション | 固溶体を用いる経口経粘膜薬剤投与形態 |
| JP2004527491A (ja) * | 2001-02-28 | 2004-09-09 | グリューネンタ−ル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬学的塩 |
| WO2005065319A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
| WO2006097361A1 (en) * | 2005-03-18 | 2006-09-21 | Ethypharm | Sublingual coated tablet |
Family Cites Families (258)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2621655A (en) | 1951-10-11 | 1952-12-16 | Kenneth L Gothard | Tablet dispensing gun |
| US3162322A (en) | 1962-03-29 | 1964-12-22 | John E Gilbertson | Sanitary dispenser for cartridges holding fluid medicants |
| US3238941A (en) | 1963-06-19 | 1966-03-08 | Frost Eng Dev | Balling gun |
| GB1142325A (en) * | 1965-05-14 | 1969-02-05 | Higham Stanley Russell | Means for administering drugs |
| US3757781A (en) | 1971-09-17 | 1973-09-11 | R Smart | Tool for administering pills to animals |
| US3780735A (en) | 1972-02-03 | 1973-12-25 | J Crouter | Dose syringe |
| US3789845A (en) | 1973-01-29 | 1974-02-05 | J Long | Capsule and tablet administration for animals |
| FR2278317A1 (fr) * | 1974-07-19 | 1976-02-13 | Commissariat Energie Atomique | Implant buccal pour administrer des produits solubilisables |
| US4060083A (en) | 1976-04-01 | 1977-11-29 | Hanson Raymond L | Pill gun |
| US4237884A (en) | 1978-03-17 | 1980-12-09 | Victor Erickson | Medication dispenser |
| GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
| US4229447A (en) | 1979-06-04 | 1980-10-21 | American Home Products Corporation | Intraoral methods of using benzodiazepines |
| US4465191A (en) | 1982-06-14 | 1984-08-14 | Darbo Rolf E | Personal tablet dispenser |
| US4474308A (en) * | 1982-09-30 | 1984-10-02 | Michel Bergeron | Tablet ejector |
| US4489853A (en) | 1982-12-15 | 1984-12-25 | Korte Jay S | Pill dispensing device |
| GB8332556D0 (en) | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| US5855908A (en) | 1984-05-01 | 1999-01-05 | University Of Utah Research Foundation | Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient |
| US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
| US5288498A (en) | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
| DE3421468A1 (de) | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
| DE3572440D1 (en) | 1984-06-19 | 1989-09-28 | Basf Ag | Gastro-resistant cylindrical pancreatine-microtablets |
| US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
| US5122127A (en) | 1985-05-01 | 1992-06-16 | University Of Utah | Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues |
| US5288497A (en) | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| US5132114A (en) | 1985-05-01 | 1992-07-21 | University Of Utah Research Foundation | Compositions and methods of manufacture of compressed powder medicaments |
| US5785989A (en) | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
| US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
| DE3632546A1 (de) | 1986-09-25 | 1988-03-31 | Knoll Ag | Dosierspender |
| US4785969A (en) | 1986-11-10 | 1988-11-22 | Pyxis Corporation | Medication dispensing system |
| ES2086291T3 (es) * | 1987-05-26 | 1996-07-01 | Sumitomo Pharma | Dispositivo para la administracion de preparados solidos. |
| US4915948A (en) | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| FR2619718B1 (fr) | 1987-09-02 | 1991-07-12 | Medibrevex | Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale |
| US4873076A (en) | 1988-04-29 | 1989-10-10 | Baker Cummins Pharmaceuticals, Inc. | Method of safely providing anesthesia or conscious sedation |
| DE68908527T2 (de) | 1988-04-29 | 1993-12-16 | Baker Norton Pharma | Verfahren zur sicheren anästhesie oder bewusstseinssedierung. |
| JPH02121039A (ja) | 1988-10-31 | 1990-05-08 | Toshiba Corp | 計算機システムの負荷予測シミュレーション方式 |
| US5236714A (en) | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
| US5112616A (en) * | 1988-11-30 | 1992-05-12 | Schering Corporation | Fast dissolving buccal tablet |
| AT391300B (de) | 1989-04-12 | 1990-09-10 | Hinterreiter Ignaz | Tablettenspender |
| US5223264A (en) | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| US5190185A (en) | 1990-05-18 | 1993-03-02 | Baxter International Inc. | Medication transport and dispensing magazine |
| GB9015522D0 (en) * | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
| CA2106483A1 (en) * | 1991-03-19 | 1992-09-20 | Vithal J. Rajadhyaksha | Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| US5296234A (en) | 1991-10-11 | 1994-03-22 | Abbott Laboratories | Holder and packaging for a hardened medicated matrix |
| US5263596A (en) | 1991-12-02 | 1993-11-23 | Williams David R | Medication dispenser station sub-assembly |
| US5348158A (en) | 1991-12-19 | 1994-09-20 | G. D. Searle & Co. | Dispenser pack for the successive dispensing of a drug |
| NL9200844A (nl) | 1992-05-13 | 1993-12-01 | De Wijdeven Gijsbertus G P Van | Inrichting en werkwijze voor het injecteren met een vaste stof. |
| US5352680A (en) * | 1992-07-15 | 1994-10-04 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists to block opioid agonist tolerance and dependence |
| US5292307A (en) | 1992-09-16 | 1994-03-08 | Dolzine Theodore W | Dispensing package for unit dosage |
| US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
| US5724957A (en) | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
| US5694919A (en) | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
| US5489689A (en) * | 1993-09-30 | 1996-02-06 | Mallinckrodt Chemical, Inc. | Preparation of piperidine derivatives |
| US5366113A (en) | 1993-12-13 | 1994-11-22 | Kim David S | Pill dispenser |
| US5489025A (en) * | 1994-03-01 | 1996-02-06 | Romick; Jerome M. | Unit-dose medication dispenser and multiple-dispenser frame therefor |
| US5507807A (en) * | 1994-03-01 | 1996-04-16 | Shippert; Ronald D. | Apparatus for the release of a substance within a patient |
| US5488953A (en) * | 1994-04-15 | 1996-02-06 | Ecocath, Inc. | Diffracting doppler-transducer |
| US5660273A (en) * | 1994-07-13 | 1997-08-26 | Centrix, Inc. | Single patient dose medicament dispenser with applicator |
| US6685013B2 (en) | 1994-07-13 | 2004-02-03 | Centrix, Inc. | Single patient dose medicament dispenser with applicator |
| US6328159B1 (en) | 1994-07-13 | 2001-12-11 | Centrix, Inc | Single patient dose medicament dispenser with applicator |
| ATE228024T1 (de) | 1994-09-16 | 2002-12-15 | Glaxosmithkline Lab Sas | Inhalator |
| US5584805A (en) | 1995-03-17 | 1996-12-17 | Sutton; Matthew R. | Animal pill-dispenser gun |
| US6881208B1 (en) | 1995-06-05 | 2005-04-19 | Joseph B. Phipps | Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| US6216033B1 (en) | 1996-05-22 | 2001-04-10 | Alza Corporation | Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| US6425892B2 (en) * | 1995-06-05 | 2002-07-30 | Alza Corporation | Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| BR9609358A (pt) | 1995-06-05 | 1999-05-18 | Alza Corp | Dispositivo para distribuição transdérmica por eletrotransporte fentanil e sufentanil |
| DE69637920D1 (de) | 1995-06-07 | 2009-06-18 | Oneil Alexander G B | Vom Patienten gesteuerte Vorrichtung zur Arzneimittelabgabe |
| US5984888A (en) | 1995-06-07 | 1999-11-16 | Kimberly-Clark Worldwide, Inc. | Applicator and coating |
| US5710551A (en) | 1995-07-26 | 1998-01-20 | Ridgeway; Donald G. | Self-medication monitoring system |
| CA2184316A1 (en) | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
| AUPN603895A0 (en) | 1995-10-19 | 1995-11-09 | University Of Queensland, The | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids |
| GB2309966A (en) | 1996-02-07 | 1997-08-13 | Harwill Ind Pty Ltd | Teat device for administering medicaments |
| US5995938A (en) | 1996-02-27 | 1999-11-30 | Whaley; Susan S. | Medication compliance system |
| EP0910427B1 (en) | 1996-07-05 | 2003-05-21 | Novo Nordisk A/S | Instrument for inserting a suppository |
| NL1003596C2 (nl) | 1996-07-15 | 1997-05-27 | Cons Health Entrepreneurs Bv | Geneesmiddelafgifte-automaat. |
| US6248789B1 (en) | 1996-08-29 | 2001-06-19 | Stuart L. Weg | Administration of ketamine to manage pain and to reduce drug dependency |
| US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
| US5954641A (en) | 1997-09-08 | 1999-09-21 | Informedix, Inc. | Method, apparatus and operating system for managing the administration of medication and medical treatment regimens |
| US5752620A (en) | 1996-11-13 | 1998-05-19 | Pearson Ventures, L.L.C. | Medication dispenser |
| US6529446B1 (en) * | 1996-12-20 | 2003-03-04 | Telaric L.L.C. | Interactive medication container |
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5950632A (en) | 1997-03-03 | 1999-09-14 | Motorola, Inc. | Medical communication apparatus, system, and method |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| US5945651A (en) | 1997-07-17 | 1999-08-31 | Chorosinski; Leonard | Remotely programmable medication dispensing system |
| JPH1147233A (ja) | 1997-07-30 | 1999-02-23 | Teikoku Seiyaku Co Ltd | 貼付剤および貼付剤の保存方法 |
| US5850937A (en) | 1997-08-14 | 1998-12-22 | Rauche; Stephen J. | Dispenser with means for alerting a user |
| CN1277550A (zh) * | 1997-09-11 | 2000-12-20 | 尼科梅德丹麦有限公司 | 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物 |
| US6660295B2 (en) | 1997-09-30 | 2003-12-09 | Alza Corporation | Transdermal drug delivery device package with improved drug stability |
| US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| AU759018B2 (en) | 1997-10-03 | 2003-04-03 | Warner-Lambert Company | Compressed nitroglycerin tablet and its method of manufacture |
| WO2000066458A1 (en) | 1997-10-30 | 2000-11-09 | HALLIN, Cristian under the firm of TELUM PRODUCTI N | A tablet dispenser |
| US5997518A (en) | 1998-01-14 | 1999-12-07 | Laibovitz; Robert A. | Apparatus and method for delivery of small volumes of liquid |
| EP1064019B1 (en) * | 1998-01-23 | 2010-11-03 | The Governing Council Of The University Of Toronto | Chemically modified mutant enzymes and methods for producing them and screening them |
| US5981552A (en) | 1998-10-23 | 1999-11-09 | Taylor Pharmaceuticals | Sublingual and buccal compositions of droperidol and method for treating migraine |
| US6576250B1 (en) | 1998-03-27 | 2003-06-10 | Cima Labs Inc. | Pharmaceutical compositions for rectal and vaginal administration |
| US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
| US6200604B1 (en) | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
| US20030091629A1 (en) | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
| US6350470B1 (en) | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| US6039251A (en) | 1998-04-16 | 2000-03-21 | Holowko; Paul L. | Method and system for secure control of a medical device |
| DE69928267T2 (de) | 1998-08-28 | 2006-06-08 | Glaxo Group Ltd., Greenford | Spender |
| SE9803240D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
| JP2000142841A (ja) | 1998-11-17 | 2000-05-23 | Lion Corp | 小形物品用容器 |
| JP3459882B2 (ja) | 1998-11-30 | 2003-10-27 | 株式会社バンダイ | 物品取出装置 |
| GB9826192D0 (en) | 1998-12-01 | 1999-01-20 | Controlled Theraputics Scotlan | Oral transmucosal delivery |
| US6131765A (en) | 1999-01-08 | 2000-10-17 | Barry; William Dean | Device for storing and dispensing solid-form medication |
| AU2879100A (en) | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
| US6680071B1 (en) | 1999-03-03 | 2004-01-20 | R. P. Scherer Technologies, Inc. | Opioid agonist in a fast dispersing dosage form |
| US6835194B2 (en) * | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| US6541021B1 (en) * | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
| US6234343B1 (en) | 1999-03-26 | 2001-05-22 | Papp Enterprises, Llc | Automated portable medication radial dispensing apparatus and method |
| US6601729B1 (en) * | 1999-03-26 | 2003-08-05 | Papp Enterprises, Llc | Automated portable medication radial dispensing apparatus and method using a carrier tape |
| US6210699B1 (en) | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
| US6762684B1 (en) | 1999-04-19 | 2004-07-13 | Accutrak Systems, Inc. | Monitoring system |
| US6319510B1 (en) | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
| US6190326B1 (en) | 1999-04-23 | 2001-02-20 | Medtrac Technologies, Inc. | Method and apparatus for obtaining patient respiratory data |
| DK1214118T4 (da) | 1999-04-29 | 2014-03-03 | Peter James Brian Lamb | Apparat til anbringelse af et ikke-flydbart objekt eller et ikke-flydbart medikament i en vagina |
| GB9911388D0 (en) | 1999-05-18 | 1999-07-14 | Glaxo Group Ltd | Dispenser |
| US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| WO2001012174A1 (en) | 1999-08-13 | 2001-02-22 | Vela Pharmaceuticals Inc. | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
| US6264983B1 (en) * | 1999-09-16 | 2001-07-24 | Rhodia, Inc. | Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| FR2799124B1 (fr) | 1999-10-01 | 2004-08-13 | Sanofi Synthelabo | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| US6382204B1 (en) | 1999-10-14 | 2002-05-07 | Becton Dickinson And Company | Drug delivery system including holder and drug container |
| US6572891B1 (en) | 1999-10-23 | 2003-06-03 | Alkaloid Ad | Sublingual oral dosage form |
| AU2427201A (en) | 1999-12-06 | 2001-06-12 | Mallinckrodt, Inc. | New methods for the syntheses of alfentanil, sufentanil and remifentanil |
| CO5270018A1 (es) * | 1999-12-11 | 2003-04-30 | Glaxo Group Ltd | Distribuidor de medicamento |
| AT408488B (de) * | 1999-12-22 | 2001-12-27 | Scan Messtechnik Gmbh | Miniaturisiertes spektrometer |
| US6294999B1 (en) | 1999-12-29 | 2001-09-25 | Becton, Dickinson And Company | Systems and methods for monitoring patient compliance with medication regimens |
| US6471645B1 (en) | 1999-12-30 | 2002-10-29 | Medtronic, Inc. | Communications system for an implantable device and a drug dispenser |
| HUP0300491A2 (en) | 2000-02-28 | 2003-07-28 | Vectura Ltd | Improvements in or relating to the delivery of oral drugs |
| US6364158B1 (en) | 2000-03-24 | 2002-04-02 | John Dimoulis | Anesthetic dispensing station and method of using same |
| WO2002011778A1 (en) * | 2000-05-10 | 2002-02-14 | University Of Kentucky Research Foundation | System and method for intranasal administration of opioids |
| DE10025946A1 (de) | 2000-05-26 | 2001-11-29 | Gruenenthal Gmbh | Wirkstoffkombination |
| AT409366B (de) * | 2000-06-20 | 2002-07-25 | Haas Beteiligungsgesellschaft | Magazin zur aufnahme und vereinzelten abgabe von tabletten |
| AU2001274307A1 (en) | 2000-06-22 | 2002-01-02 | Pharmasol Ltd | Pharmaceutical compositions |
| DE20122843U1 (de) * | 2000-07-31 | 2008-06-26 | Nycomed Danmark Aps | Fentanyl Zusammensetzung zur nasalen Anwendung |
| NZ524124A (en) * | 2000-08-18 | 2004-09-24 | Pharmacia Corp | Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| US20020026330A1 (en) * | 2000-08-23 | 2002-02-28 | Klein Edward E. | System and method for patient medication management and compliance using a portable computing device |
| US6417184B1 (en) | 2000-09-19 | 2002-07-09 | David M. Ockert | Triple drug therapy for the treatment and prevention of acute or chronic pain |
| GB2368061B (en) | 2000-10-20 | 2005-05-11 | Gw Pharmaceuticals Ltd | Dose dispensing apparatus |
| US20050054942A1 (en) * | 2002-01-22 | 2005-03-10 | Melker Richard J. | System and method for therapeutic drug monitoring |
| US20020160043A1 (en) | 2001-02-27 | 2002-10-31 | Dennis Coleman | Compositions and method of manufacture for oral dissolvable dosage forms |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| JP4850346B2 (ja) * | 2001-03-15 | 2012-01-11 | 救急薬品工業株式会社 | 粘膜貼付剤 |
| AU2002336246B8 (en) | 2001-03-15 | 2006-02-02 | Creare Incorporated | Nebulizer having cooling chamber |
| EP1243524A3 (en) | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| GB0108228D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
| GB0108215D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
| US7125561B2 (en) * | 2001-05-22 | 2006-10-24 | Euro-Celtique S.A. | Compartmentalized dosage form |
| JP2005503425A (ja) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
| NZ529417A (en) * | 2001-05-24 | 2006-11-30 | Alexza Pharmaceuticals Inc | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US20030051728A1 (en) * | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US6564967B1 (en) | 2001-06-29 | 2003-05-20 | Brown & Williamson Tobacco Corporation | Child resistant tablet dispenser |
| US20030022910A1 (en) | 2001-07-05 | 2003-01-30 | R.T. Alamo Ventures I, Inc. | Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine |
| US20030008005A1 (en) | 2001-07-05 | 2003-01-09 | R.T. Alamo Ventures, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US20030017175A1 (en) | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US20030068356A1 (en) | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
| FR2827517B1 (fr) * | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
| AU2002321885A1 (en) * | 2001-08-03 | 2003-02-24 | Hill-Rom Services, Inc. | Patient point-of-care computer system |
| US7144587B2 (en) * | 2001-08-06 | 2006-12-05 | Euro-Celtique S.A. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent |
| US7044302B2 (en) * | 2001-09-19 | 2006-05-16 | Avancen, Inc. | Patient controlled timed oral medication dispenser |
| US7743923B2 (en) | 2001-09-19 | 2010-06-29 | Avanced MOD Corporation | Patient controlled timed medication dispenser |
| US7896192B2 (en) * | 2001-09-19 | 2011-03-01 | Avancen MOD Corp. | Patient controlled timed medication dispenser |
| CA2461044A1 (en) * | 2001-09-26 | 2003-04-03 | Pharmacia Corporation | Intraorally disintegrating valdecoxib compositions |
| JP2005506885A (ja) | 2001-10-22 | 2005-03-10 | スリーエム イノベイティブ プロパティズ カンパニー | 経皮/経粘膜パッチ包装 |
| US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| US20030130314A1 (en) | 2001-12-17 | 2003-07-10 | Pascal Druzgala | Analgesic delivery systems and methods of use |
| CA2366887C (en) * | 2001-12-31 | 2011-11-01 | Michael Petersen | Replicate incorporating an electronic content monitoring system for use in form-fill-seal applications |
| EP1478420B1 (en) * | 2002-02-22 | 2009-09-09 | G W Pharma Limited | Dose dispensing system and apparatus |
| US7204425B2 (en) * | 2002-03-18 | 2007-04-17 | Precision Dynamics Corporation | Enhanced identification appliance |
| US7074426B2 (en) * | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
| GB0209783D0 (en) | 2002-04-29 | 2002-06-05 | Glaxo Group Ltd | Medicament dispenser |
| US6961541B2 (en) | 2002-05-24 | 2005-11-01 | Aeroscout, Inc. | Method and apparatus for enhancing security in a wireless network using distance measurement techniques |
| US6793075B1 (en) | 2002-05-30 | 2004-09-21 | Michael Jeter | Container for dispensing a liquid and method of using the same |
| DE10226494A1 (de) | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| ATE424010T1 (de) * | 2002-06-21 | 2009-03-15 | Glaxo Group Ltd | Betätigungsanzeiger für eine abgabevorrichtung |
| JP2004051502A (ja) | 2002-07-17 | 2004-02-19 | Jcr Pharmaceuticals Co Ltd | 成長ホルモン含有安定化粉末製剤 |
| WO2004014567A1 (en) * | 2002-08-06 | 2004-02-19 | Glaxo Group Limited | A dispenser |
| US9486581B2 (en) | 2002-09-11 | 2016-11-08 | Becton, Dickinson And Company | Injector device with force lock-out and injection rate limiting mechanisms |
| US7295890B2 (en) * | 2002-09-26 | 2007-11-13 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
| US6963289B2 (en) | 2002-10-18 | 2005-11-08 | Aeroscout, Ltd. | Wireless local area network (WLAN) channel radio-frequency identification (RFID) tag system and method therefor |
| US6999092B2 (en) * | 2002-10-25 | 2006-02-14 | Fujitsu Limited | Image display apparatus in which a specific area display attribute is modifiable |
| US6726053B1 (en) * | 2002-10-29 | 2004-04-27 | John E. Harrold | Child resistant multiple dosage blister pack dispenser |
| JP3447009B1 (ja) | 2002-10-29 | 2003-09-16 | 實 平垣 | 構築物用構成体およびその製造方法 |
| GB0226022D0 (en) * | 2002-11-07 | 2002-12-18 | Corporate Intellectual Propert | Device |
| NZ540282A (en) | 2002-11-18 | 2008-06-30 | Yaupon Therapeutics Inc | Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| AU2003297041B2 (en) | 2002-12-13 | 2009-02-26 | Alphavax, Inc. | Alphavirus particles and methods for preparation |
| US7264139B2 (en) | 2003-01-14 | 2007-09-04 | Hypoguard Limited | Sensor dispensing device |
| ES2270335T7 (es) | 2003-01-31 | 2012-03-16 | Orexo Ab | Composicion farmaceuta de efecto. |
| US20040253307A1 (en) | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
| KR20120066688A (ko) * | 2003-02-24 | 2012-06-22 | 파마슈티칼 프로덕션스, 인크. | 경점막 약물 전달 시스템 |
| US20060062812A1 (en) | 2003-03-11 | 2006-03-23 | Calvin Ross | Novel compositions |
| GB0305581D0 (en) | 2003-03-11 | 2003-04-16 | Dallas Burston Ltd | Dispensing devices |
| CA2522471A1 (en) | 2003-04-14 | 2004-10-28 | Pain Therapeutics, Inc. | Methods for the treatment of pain comprising opioid antagonists |
| US7306812B2 (en) | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
| US7276246B2 (en) | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
| US6914668B2 (en) | 2003-05-14 | 2005-07-05 | International Technologies (Laser) Ltd. | Personal identification verification and controlled substance detection and identification system |
| BR0302017B1 (pt) * | 2003-06-02 | 2014-10-29 | Ems Sigma Pharma Ltda | Composição farmacêutica sublingual a base de um agonista do receptor central de benzodiazepínicos |
| US7819847B2 (en) * | 2003-06-10 | 2010-10-26 | Hewlett-Packard Development Company, L.P. | System and methods for administering bioactive compositions |
| US7118550B2 (en) | 2003-07-10 | 2006-10-10 | B. Braun Medical | Side-delivery suppository dispenser |
| US20050049464A1 (en) | 2003-08-29 | 2005-03-03 | Lassers Harold Aaron | Remote pharmaceutical administration device |
| US7248165B2 (en) | 2003-09-09 | 2007-07-24 | Motorola, Inc. | Method and apparatus for multiple frequency RFID tag architecture |
| US20050065175A1 (en) * | 2003-09-24 | 2005-03-24 | Xanodyne Pharmacal, Inc. | Oral transmucosal methadone |
| CA2540895C (en) * | 2003-10-02 | 2016-08-02 | Elan Pharmaceuticals, Inc. | Combinations of ziconotide and opioids for reducing pain |
| US8157788B2 (en) * | 2003-11-06 | 2012-04-17 | Paolo L. Manfredi | Multi-site drug delivery platform |
| US7540998B2 (en) | 2003-11-19 | 2009-06-02 | Biocompatibles Uk Limited | Delivery system and prescription method for interstitial radiation therapy using enhanced parametric release sterilization techniques |
| US7780973B2 (en) | 2003-12-15 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Method and device for minimally invasive implantation of biomaterial |
| US6999028B2 (en) | 2003-12-23 | 2006-02-14 | 3M Innovative Properties Company | Ultra high frequency radio frequency identification tag |
| EP1708685B1 (en) | 2003-12-31 | 2011-03-09 | Cima Labs Inc. | Effervescent oral opiate dosage forms and methods of administering oxycodone |
| WO2005065317A2 (en) | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Effervescent oral fentanyl dosage form |
| US20070036853A1 (en) | 2003-12-31 | 2007-02-15 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
| US20050150489A1 (en) | 2004-01-12 | 2005-07-14 | Steve Dunfield | Dispensing medicaments based on rates of medicament action |
| EP1711220A1 (en) | 2004-01-16 | 2006-10-18 | Biodel, Inc. | Sublingual drug delivery device |
| WO2005097075A2 (en) | 2004-03-30 | 2005-10-20 | Euro-Celtique S.A. | Tamper resistant dosage form comprising an adsorbent and an adverse agent |
| US20050226923A1 (en) | 2004-04-07 | 2005-10-13 | Gassert Chad M | Venlafaxine compositions in the form of microtablets |
| US7004111B2 (en) | 2004-05-26 | 2006-02-28 | Keryl Olson | Treat dispenser |
| US20060026035A1 (en) | 2004-07-28 | 2006-02-02 | William Younkes | Computer aided interactive medical management information and control system and method |
| US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
| GB0420016D0 (en) | 2004-09-09 | 2004-10-13 | Leuven K U Res & Dev | Controlled release oral delivery system |
| US20060067978A1 (en) * | 2004-09-29 | 2006-03-30 | Bausch & Lomb Incorporated | Process for preparing poly(vinyl alcohol) drug delivery devices |
| US7388493B2 (en) | 2004-10-08 | 2008-06-17 | Bartronics America, Inc. | Method and system for preventing unauthorized removal and use of an RFID apparatus |
| US7119690B2 (en) | 2004-10-08 | 2006-10-10 | Proximities, Inc. | Identification band using serpentine paths to detect tampering |
| JP2008518204A (ja) | 2004-10-21 | 2008-05-29 | バイエル・ヘルスケア・エルエルシー | センサ−分与装置及びセンサを引き出す機構 |
| CN2776369Y (zh) | 2004-10-22 | 2006-05-03 | 瓦索金爱尔兰有限公司 | 分配系统 |
| US20060089858A1 (en) | 2004-10-25 | 2006-04-27 | Tun Ling | Means and method of applying RFID and PKI technologies for patient safety |
| MX2007011977A (es) | 2005-03-28 | 2007-12-07 | Orexo Ab | Composiciones farmaceuticas novedosas utiles en el tratamiento del dolor. |
| US20070020186A1 (en) | 2005-07-22 | 2007-01-25 | Alpex Pharma S.A. | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| WO2007035913A2 (en) | 2005-09-21 | 2007-03-29 | Kurve Technology, Inc. | Medicament delivery control, monitoring, and reporting system and method |
| US20070104763A1 (en) * | 2005-11-10 | 2007-05-10 | Navinta Llc | Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making |
| ES2551305T3 (es) * | 2005-12-28 | 2015-11-17 | Alza Corporation | Formulaciones terapéuticas estables |
| US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
| US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US9289583B2 (en) * | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| US8535714B2 (en) * | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| US8252329B2 (en) * | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| US8357114B2 (en) * | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
| US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
| WO2007084290A2 (en) | 2006-01-12 | 2007-07-26 | Orexigen Therapeutics, Inc. | Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain |
| US20070190130A1 (en) | 2006-02-16 | 2007-08-16 | Mark William A | Protein hydrolysate excipients |
| US20070260491A1 (en) | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
| US7581657B2 (en) | 2006-05-15 | 2009-09-01 | Dickmann Alexander J | Bandage dispenser |
| US20070286900A1 (en) | 2006-06-09 | 2007-12-13 | Catherine Herry | Low dose tablets of opioid analgesics and preparation process |
| US20070299687A1 (en) | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
| KR101445891B1 (ko) | 2007-01-05 | 2014-10-02 | 아셀알엑스 파마슈티컬스 인코퍼레이티드 | 경구 경점막 제형의 투여를 위한 저장 및 분배 장치 |
| US7744558B2 (en) | 2007-06-06 | 2010-06-29 | Maag R John | Pill plunger |
| US20090010992A1 (en) * | 2007-07-03 | 2009-01-08 | Aceirx Pharmaceuticals, Inc. | Drug formulations for oral transmucosal delivery to pediatric patients |
| JP5632284B2 (ja) | 2007-08-07 | 2014-11-26 | エーセルアールエックス ファーマシューティカルズ, インコーポレイテッド | 経口経粘膜剤形を使用する処置時の鎮静および無痛のための組成物および方法 |
| US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| US8548623B2 (en) | 2009-03-18 | 2013-10-01 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| US8062248B2 (en) | 2009-07-14 | 2011-11-22 | Charles Edward Kindel | Pill dispenser for pets |
| US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| US20110288128A1 (en) | 2010-05-21 | 2011-11-24 | Acelrx Pharmaceuticals, Inc. | Oral Transmucosal Administration of Sufentanil |
-
2007
- 2007-11-14 US US11/985,162 patent/US8865743B2/en active Active
- 2007-12-28 CA CA2673856A patent/CA2673856C/en active Active
- 2007-12-28 JP JP2009544900A patent/JP2010532745A/ja active Pending
- 2007-12-28 PT PT07870025T patent/PT2114383E/pt unknown
- 2007-12-28 DK DK07870025.9T patent/DK2114383T3/da active
- 2007-12-28 WO PCT/US2007/089018 patent/WO2008085765A2/en not_active Ceased
- 2007-12-28 KR KR1020097016353A patent/KR101545754B1/ko active Active
- 2007-12-28 DE DE602007007991T patent/DE602007007991D1/de active Active
- 2007-12-28 EP EP07870025A patent/EP2114383B1/en active Active
- 2007-12-28 AT AT07870025T patent/ATE474564T1/de not_active IP Right Cessation
-
2014
- 2014-10-17 US US14/517,260 patent/US9320710B2/en active Active
-
2016
- 2016-04-06 US US15/092,127 patent/US9744129B2/en active Active
-
2017
- 2017-07-20 US US15/655,316 patent/US10245228B2/en active Active
-
2018
- 2018-10-05 US US16/153,301 patent/US10507180B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002526440A (ja) * | 1998-09-24 | 2002-08-20 | ダイアバクト・エイ・ビー | 急性疼痛の処置のためのフェンタニル組成物 |
| JP2003512402A (ja) * | 1999-10-27 | 2003-04-02 | アネスタ・コーポレーション | 固溶体を用いる経口経粘膜薬剤投与形態 |
| JP2004527491A (ja) * | 2001-02-28 | 2004-09-09 | グリューネンタ−ル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬学的塩 |
| WO2005065319A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
| WO2006097361A1 (en) * | 2005-03-18 | 2006-09-21 | Ethypharm | Sublingual coated tablet |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016510345A (ja) * | 2014-02-07 | 2016-04-07 | サイラブス, ファーマシューティカルズ | 全自然非毒性舌下薬剤の送達システム |
| JP2018030896A (ja) * | 2014-02-07 | 2018-03-01 | サイラブス, ファーマシューティカルズ | 全自然非毒性舌下薬剤の送達システム |
Also Published As
| Publication number | Publication date |
|---|---|
| US9744129B2 (en) | 2017-08-29 |
| DE602007007991D1 (de) | 2010-09-02 |
| US20190125659A1 (en) | 2019-05-02 |
| WO2008085765A3 (en) | 2008-11-27 |
| DK2114383T3 (da) | 2010-10-04 |
| US9320710B2 (en) | 2016-04-26 |
| KR101545754B1 (ko) | 2015-08-19 |
| WO2008085765A2 (en) | 2008-07-17 |
| CA2673856A1 (en) | 2008-07-17 |
| US8865743B2 (en) | 2014-10-21 |
| US20160213606A1 (en) | 2016-07-28 |
| EP2114383B1 (en) | 2010-07-21 |
| US20180161270A1 (en) | 2018-06-14 |
| CA2673856C (en) | 2018-11-27 |
| US20150105424A1 (en) | 2015-04-16 |
| ATE474564T1 (de) | 2010-08-15 |
| US10507180B2 (en) | 2019-12-17 |
| EP2114383A2 (en) | 2009-11-11 |
| US10245228B2 (en) | 2019-04-02 |
| US20080268023A1 (en) | 2008-10-30 |
| PT2114383E (pt) | 2010-08-16 |
| KR20090099009A (ko) | 2009-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10507180B2 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
| US8226978B2 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
| JP6138196B2 (ja) | 経粘膜剤形の投与のための貯蔵および投与デバイス | |
| US9289583B2 (en) | Methods for administering small volume oral transmucosal dosage forms using a dispensing device | |
| US10709881B2 (en) | Apparatus for administering small volume oral transmucosal dosage forms | |
| JP5322949B2 (ja) | 経口腔粘膜剤形の投与のための貯蔵および投与デバイス | |
| WO2010107761A1 (en) | Improved storage and dispensing devices for administration of oral transmucosal dosage forms | |
| CN101621994B (zh) | 用于治疗疼痛的含舒芬太尼的小量口腔跨粘膜剂型 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101227 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111219 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121228 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130327 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130403 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130426 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130508 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130524 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130531 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130905 |